Plasma adrenaline concentration is lower in post-obese than in never-obese women in the basal state, in response to sham-feeding and after food intake.
1. Plasma pancreatic polypeptide, plasma catecholamine, blood glucose, plasma insulin and plasma peptide YY concentrations were studied to assess differences between eight formerly obese and eight never-obese control women during 25 min of sham-feeding (with the sight and smell of an English breakfast) and for 5 h after they had ingested the meal (3514 kJ, 50% fat, 35% carbohydrate). The post-obese women had maintained their normal body weight for at least 3 months before the study. 2. The plasma noradrenaline concentration was not different between the groups either during fasting (post-obese women 0.08 +/- 0.01 ng/ml versus control women 0.10 +/- 0.01 ng/ml) or in the significant postprandial increase (P < 0.001). The plasma adrenaline concentration increased significantly during sham-feeding in the control group from 0.024 +/- 0.004 ng/ml to 0.033 +/- 0.004 ng/ml (P = 0.02) in contrast with the post-obese women, who had significantly lower plasma concentrations of adrenaline in the fasting state (post-obese 0.016 +/- 0.003 ng/ml versus control women 0.024 +/- 0.004 ng/ml, P = 0.003), during sham-feeding (post-obese women 0.018 +/- 0.002 ng/ml versus control women 0.033 +/- 0.004 ng/ml, P = 0.003) and in the postprandial increase (P = 0.003). The maximal postprandial response concentrations recorded 5 h after the meal were 0.025 +/- 0.003 ng/ml in post-obese women and 0.035 +/- 0.004 ng/ml in control subjects (P = 0.04). There were no significant differences in plasma pancreatic polypeptide, plasma peptide YY, plasma insulin, or blood glucose concentrations between the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Bryde Andersen
H
H
Department of Internal Medicine and Endocrinology, Herlev Hospital, University of Copenhagen, Denmark.
Raben
A
A
Astrup
A
A
Christensen
N J
NJ
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002149:Energy Intake / Q000502:physiology*; D004837:Epinephrine / Q000097:blood*; D005215:Fasting / Q000502:physiology; D005260:Female; D005768:Gastrointestinal Hormones / Q000097:blood; D006801:Humans; D007328:Insulin / Q000097:blood; D009638:Norepinephrine / Q000097:blood; D009765:Obesity / Q000097:blood*; D010191:Pancreatic Polypeptide / Q000097:blood; D019894:Peptide YY; D010455:Peptides / Q000097:blood; D013997:Time Factors; D015431:Weight Loss / Q000502:physiology*
D001786:Blood Glucose; D005768:Gastrointestinal Hormones; D007328:Insulin; D010455:Peptides; D019894:Peptide YY; D010191:Pancreatic Polypeptide; D009638:Norepinephrine; D004837:Epinephrine